At 9.7% CAGR, the Asia Pacific Ventilators Market is projected to be worth US$ 2,280.95 million by 2028, says Business Market Insights

According to Business Market Insights’ research, the Asia Pacific ventilators market was valued at US$  1,172.92 million in 2022 and is expected to reach US$ 2,048.29 million by 2028, registering a CAGR of 9.7% from 2022 to 2028. Growing prevalence of respiratory diseases are the critical factors attributed to the Asia Pacific ventilators market expansion.      

Respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, acute lower respiratory tract infections, tuberculosis, and lung cancer are among the most common causes of severe illness and death. Urbanization, growing pollution, unhealthy lifestyle habits, and high tobacco smoking prevalence are among the factors leading to the surge in the number of respiratory and cardiovascular disease cases. These diseases can cause acute respiratory failure, treatment of which requires mechanical ventilation. A ventilator assists the patient with respiratory diseases or other such conditions in breathing as these disorders make breathing difficult or impossible. Thus, the growing prevalence of respiratory diseases increasing demand for ventilators fueling the Asia Pacific ventilators market growth.

On the contrary, complications associated with the use of ventilators hampers the Asia Pacific ventilators market .

Based on mobility, the Asia Pacific ventilators market is segmented into intensive care ventilators and portable/transportable ventilators. The intensive care ventilators segment held 64.7% share of Asia Pacific ventilators market  in 2022, amassing US$ 758.38 million. It is projected to garner US$ 1,303.69 million by 2028 to expand at 9.4% CAGR during 2022–2028.

Based on clinical indication, the Asia Pacific ventilators market is segmented into medical (in general), trauma, neurological (emergency cranial surgery or with complex skull base tumor resections), surgical, and others. The medical (in general) segment held 54.8% share of Asia Pacific ventilators market in 2022, amassing US$ 642.73 million. It is projected to garner US$  1,106.88 million by 2028 to expand at 9.5% CAGR during 2022–2028.

Based on patients, the Asia Pacific ventilators market is segmented into adult and pediatric & neonatal. The adult segment held 85.9% share of Asia Pacific ventilators market in 2022, amassing US$ 1,007.46 million. It is projected to garner US$ 1,792.40 million by 2028 to expand at 10.1% CAGR during 2022–2028.

Based on interface, the Asia Pacific ventilators market is segmented into invasive and non-invasive. The invasive segment held 58.7% share of Asia Pacific ventilators market in 2022, amassing US$  688.24 million. It is projected to garner US$ 1,175.17 million by 2028 to expand at 9.3% CAGR during 2022–2028.

Based on mode, the Asia Pacific ventilators market is segmented into combined mode ventilation, volume mode, ventilation, pressure mode ventilation, neurally adjusted ventilatory assist (NAVA), inverse ratio ventilation (IRV), prone ventilation, high-frequency oscillatory ventilation (HFOV), high-frequency percussive ventilation (HFPV), and other. The combined mode ventilation segment held 44.4% share of Asia Pacific ventilators market in 2022, amassing US$ 521.24 million. It is projected to garner US$  970.63 million by 2028 to expand at 10.9% CAGR during 2022–2028.

Based on end user, the Asia Pacific ventilators market is segmented into hospitals & clinics, home care, ambulatory care centers, and emergency medical services (EMS). The hospitals & clinics segment held 68.2% share of Asia Pacific ventilators market in 2022, amassing US$ 799.77 million. It is projected to garner US$ 1,432.97 million by 2028 to expand at 10.2% CAGR during 2022–2028.

Based on country, the Asia Pacific ventilators market  has been categorized into Japan, China, India, Australia, South Korea, and the Rest of Asia Pacific. Our regional analysis states that Japan captured 31.1% share of Asia Pacific ventilators market  in 2022. It was assessed at US$  365.06 million in 2022 and is likely to hit US$ 628.56 million by 2028, exhibiting a CAGR of 9.5% during the forecast period.

Key players dominating the Asia Pacific ventilators market  are BPL Medical Technologies; Dragerwerk AG & Co. KGaA; Fisher & Paykel Healthcare Limited; General Electric Co; Getinge AB; Hamilton Medical; Koninklijke Philips NV; Medtronic Plc; ResMed Inc.; and VYAIRE MEDICAL, INC., among others.

• In June 2021; Vyaire Medical's new distribution partnership in India significantly expands the company's footprint and provides greater accessibility to high-quality pulmonary screening, testing, and treatment for the country's 1.4 billion people. The partnership brings Vyaire Medical's portfolio of diagnostic and treatment products to doctors, clinics, hospitals, universities, and diagnostic centers at a time when the respiratory disease burden of the country has been further stretched because of the COVID-19 pandemic. 

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com